Europe's Beating Cancer Plan vs. a Reality of Inequality. Why Prevention Depends on Us Today?

Every year, cancer claims nearly 1.1 million lives in the European Union, with associated costs exceeding 100 billion euros. The statistics are stark: it's predicted that one in two EU citizens will be diagnosed with cancer in their lifetime. In response to this escalating crisis, the EU launched "Europe's Beating Cancer Plan" (EBCP) with a budget of 4 billion euros (approx. 17 billion PLN). This plan is not about generalities but a highly professional and detailed approach containing ambitious goals for member states to achieve, giving us a real chance to take up the challenge. But are good intentions and large sums of money enough to truly halt these statistics?

The answer to this question comes from the latest, insightful audit conducted by the European Court of Auditors (ECA) – an EU institution that oversees the execution of the European budget. The report paints a picture of a powerful initiative that, while incredibly necessary and already saving lives, sometimes grapples with chaos, bureaucracy, and dramatic inequalities between member states when confronted with reality.

Pitfalls of Disorganization and Duplicated Efforts

According to the ECA report, the EU plan is impressive in its scope – it covers the entire patient journey: from prevention and early detection to treatment and improving the quality of life for survivors. Unfortunately, its implementation sometimes resembles an orchestra playing without a precise conductoAuditors expose an uncomfortable truth: the system suffers from a lack of close coordination between member states and a lack of tools to measure real impact. An example? The EU is funding several separate, similar mobile applications (like iBeCHANGE or BUMPER) that have the exact same goal – education and promoting prevention. Duplicating these efforts leads to an inefficient dispersion of funds. Furthermore, the future of many promising EBCP initiatives after 2027 – when current funding ends – is highly uncertain due to a lack of consensus among member states. There is no long-term guarantee that these programs will survive.

Inequalities That Cost Lives

This is perhaps the most striking conclusion from the latest EU brochure. The published European Cancer Inequalities Registry (ECIR) reveals a dramatic gap between individual member states, proving that a postal code still largely determines our chances of survival.

The numbers show that:

• HPV vaccinations (preventing cervical cancer, among others): While Portugal has an impressive 91% vaccination rate among 15-year-old girls, Bulgaria has only 7%.

• Screening tests (breast cancer): In Nordic countries like Denmark and Finland, over 75% of eligible women participate in mammography. Meanwhile, in countries like Poland, Romania, and Bulgaria, this rate drops drastically below 40%.

The ECA report alerts that giant disparities also exist within countries themselves. Residents of smaller towns often have significantly more difficult access to oncologists and modern diagnostics compared to residents of cities and metropolitan areas, which is unfortunately also the case in Poland. EU funds, though flowing generously, still do not reach proportionally those regions that need them most. It's worth noting that in Poland, data collection on cancer diseases and their treatment, while progressing, still faces challenges related to fragmented IT systems and the need for better data integration between different medical facilities. This hinders precise monitoring of intervention effectiveness and identification of areas requiring the most support.

Tomorrow's Medicine vs. the System's Slow Grind

Of course, not everything is bleak. The EBCP is also a powerful stimulus for innovation. Thanks to the European Cancer Imaging Initiative, artificial intelligence is already learning from millions of anonymized medical images, which will revolutionize and accelerate cancer diagnostics in the future. Knowledge exchange within European cancer networks is a step in the right direction.

However, as the auditors note, these innovations often remain at the pilot project stage. Without systemic implementation in individual member states, they will remain mere scientific curiosities rather than a real path to helping patients.

What Does This Mean for Us? We Take Responsibility into Our Own Hands

Reading the ECA report shows how crucial EU-level coordination is. However, systemic changes and the implementation of top-down health policies take years. As patients and citizens, we cannot passively wait for EU directives to eliminate local shortages in doctor appointments, even if they are eventually implemented by all member states.

Since, according to the WHO, up to 40% of cancers can be avoided, protection must begin with our proactive attitude, through regular preventive check-ups or proven and effective vaccinations. This is why modern tools supporting prevention, such as Wellysa, are so important today. Faced with a fragmented and often inefficient healthcare system, even European lawmakers and auditors are aware that we need digital support. Platforms that help navigate the maze of recommendations, remind us of key screening tests, and facilitate the building of daily, cancer-protective habits are becoming another essential piece of the healthcare puzzle. 

The fight against cancer is the responsibility of national governments, institutions, and the EU budget. However, as long as procedures are drowned in a lack of political consensus, our daily choices, periodic check-ups, and awareness of our own health remain our first and most effective line of defense. Let's fight for as many healthy years as possible – together and individually – each doing our part.